VANRAFIA
DEAD

Serial Number

97626972

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VANRAFIA Trademark

Serial Number: 97626972

VANRAFIA is a trademark filed by NOVARTIS AG on October 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 11, 2022

Registration Date

Not Registered

Published for Opposition

July 18, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 13, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 13, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 11, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 10, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 9, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 9, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2023 CNSA
ASSIGNED TO EXAMINER
Jun 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2022 NWOS
NEW APPLICATION ENTERED
Oct 14, 2022 NWAP